FA vs DLB
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
FA · First Advantage$21.07 ▼ 0.43%
DLB · Dolby Laboratories$55.33 ▲ 1.02%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- FA +54.8%
- DLB -15.2%
Head to head
| Metric | FA | DLB |
|---|---|---|
| Price | $21.07 | $55.33 |
| Change today | ▼ 0.43% | ▲ 1.02% |
| Market cap | $3.62B | $5.13B |
| Return, 3 months | +1.8% | -16.2% |
| Return, year to date | +45.0% | -12.3% |
| Return, 1 year | +54.5% | -16.1% |
| P/E (TTM) | 84.3 | 20.5 |
| P/B | 2.7 | 2.0 |
| P/E percentile vs own 5y | 76th | 25th |
| Dividend yield | – | 2.60% |
| Revenue growth (YoY, latest qtr) | +13.8% | -3.3% |
| Net profit growth (YoY) | +690.2% | -37.2% |
| Gross margin | 45.2% | 87.6% |
| Operating margin | 11.4% | 19.3% |
| Net margin | 2.5% | 16.7% |
| Return on equity | 3.3% | 8.7% |
| Analyst target vs. price | +31.0% | +58.1% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 48 | 27 |
| 30-day volatility | 45.8% | 30.1% |
| Max drawdown, 1 year | -43.1% | -29.3% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- DLB is the largest of the group by market value.
- FA has returned the most over the past year.
- DLB carries the lowest trailing P/E.
- FA is growing revenue fastest.
- DLB keeps the most profit per dollar of sales.
- DLB has been the calmest stock over the last 30 days.